Skip to content
Open access

Formulation and Evaluation of Carbamazepine Floating Matrix Sustained-Release Tablets Using Psyllium Husk Approach for Sustained Immunosuppression in Rheumatoid Arthritis

Oct 2026 · International journal of allied medical sciences and clinical research · 0 citations

TL;DR

The present study aimed to formulate and evaluate effervescent floating matrix sustained-release tablets of carbamazepine using Eudragit L-100 and psyllium husk as matrix-forming materials using Eudragit L-100 and psyllium husk as matrix-forming materials for Gastro-retentive floating systems.

Abstract

The present study aimed to formulate and evaluate effervescent floating matrix sustained-release tablets of carbamazepine using Eudragit L-100 and psyllium husk as matrix-forming materials. Gastro-retentive floating systems are designed to remain buoyant in gastric contents and release drug over an extended period, potentially supporting delivery to the upper gastrointestinal tract. Five formulations (F1–F5) were prepared by direct compression. Sodium bicarbonate and citric acid were incorporated as gas-generating components, while microcrystalline cellulose, talc and magnesium stearate served as formulation auxiliaries. Powder blends were assessed for flow-related parameters, and the compressed tablets were evaluated for physical quality, drug content, buoyancy, swelling, in-vitro release and drug–excipient compatibility. The source study reports a carbamazepine absorption maximum (λmax) of 283 nm in 0.1 N hydrochloric acid and linearity over 5–20 μg/mL. Drug content across the formulations ranged from 97.18% to 100.4%. Formulation F4 showed a reported buoyancy lag time of 14 seconds, an 8-hour swelling index of 65.57%, and 97.86% drug release at 12 hours. FTIR and DSC observations were interpreted as indicating no significant interaction between carbamazepine and the selected polymers. Based on the reported in-vitro results, F4 was selected as the optimized formulation. Further confirmation, including reproducibility, stability and in-vivo evaluation, is needed before drawing clinical conclusions.

Read PDF

Similar papers

Sep 2026

Natural Polymer-Based Gastroretentive Floating-Bioadhesive Matrix Tablets of Furosemide: Formulation, Optimization, and in Vitro Evaluation

Background: Furosemide exhibits low and variable oral bioavailability owing to its limited absorption window in the upper gastrointestinal tract, short gastric residence time, and poor aqueous solubility. The present study aimed to develop and optimize a floating-bioadhesive matrix tablet of furosemide using Delonixreg...

A. Gayke · 0 citations
Open access Oct 2026

Formulation and Optimization of Sustained-Release Gastroretentive Microspheres of Vonoprazan Using Box– Behnken Design

Background: Vonoprazan is a novel potassium-competitive acid blocker (P-CAB) with potent acid-suppressive activity; however, its therapeutic efficacy may be limited by rapid gastric emptying. The present study aimed to formulate and optimize sustained-release gastroretentive microspheres of vonoprazan using the ionotro...

Nari Umarani, Kishore Kumar Hotha, P. Kulkarni et al. · 0 citations
Sep 2026

DEVELOPMENT AND CHARACTERIZATION OF GASTRORETENTIVE FLOATING TABLETS OF DOMPERIDONE MALEATE AND FAMOTIDINE USING HYDROPHILIC POLYMER MATRIX.

Background Gastroretentive dosage forms are designed to remain in the stomach for an extended period and may improve drug delivery when absorption is favored in the upper gastrointestinal tract or is influenced by gastrointestinal pH. Domperidone maleate and famotidine are used in the management of upper gastrointesti...

Jakir Husain · 0 citations
Open access Sep 2026

Formulation and Evaluation of Controlled-Release Repaglinide Tablets Using Eudragit RS100 and Carbopol P974 NF Polymer Combinations

Repaglinide is a short-acting insulin secretagogue whose short half-life necessitates frequent dosing, compromising adherence. Controlled-release (CR) matrix tablets combining hydrophobic and hydrophilic polymers can sustain drug release and reduce dosing frequency. To formulate and evaluate CR repaglinide tablets us...

Haseena Ghaffar, Ghulam Shahwani, Abdul Ghaffar et al. · 0 citations
Sep 2026

Development and Evaluation of a Prolonged-Release Imeglimin Hydrochloride Matrix Tablet using Hydrophilic-Hydrophobic Polymer Blends

Objective: The present work was aimed at designing and optimizing a prolonged-release matrix tablet of Imeglimin hydrochloride (500 mg) employing binary polymer combinations of hydroxypropyl methylcellulose (HPMC) K100M and Carbopol 940P as rate-controlling polymers for sustained antihyperglycemic action over 12 hours,...

Shailendra Singh Narwariya · 1 citation
Open access 2025

FORMULATION AND EVALUATION OF GRDDS TABLETS OF REPAGLINIDE USING GRAFTED NATURAL POLYMERS

Objective: To develop and optimize effervescent gastroretentive floating matrix tablets (EGFMT) of repaglinide using grafted gum (GG-N) of two viscosity grades (1% and 2% solutions) as the matrix-forming polymer and sodium bicarbonate as the gas-generating agent, in order to prolong gastric residence and sustain drug r...

Rim Mohamed Farss Awida, A. Rani, Chandu Babu Rao · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.